Health Care · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · CIK 1369290 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $0.96Day −9.91%Mkt cap $37M1Y −52.7%Off 52W high −55.3%Vol (1Y) 96.3%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,284 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest6.2% of sh out |
| Days to cover6.9d |
| 13F net flow (QoQ)−3.11% |
| Top-10 13F concentration78.6% |
| Next report (est.)2026-08-06 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$41.2M |
| Earnings (TTM)-$15.1M |
| ROE−86.2% |
| Net margin−38.1% |
| ROIC−227.8% |
| Debt / equity1.24× |
| Sales growth 3Y38.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+4.9% |
| 1Y−52.7% |
| 3Y+33.0% |
| 5Y−88.1% |
| Since incept. (ann.)−20.1% |
Total return through 2026-07-28 · series begins 2017-06-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)96.3% |
| Ann. volatility (3Y)99.6% |
| Sharpe (1Y)−0.29 |
| Sharpe (3Y)0.56 |
| Max drawdown (1Y)−68.3% |
| Max drawdown (3Y)−90.8% |
| Beta (3Y vs SPY)3.18 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3.8M | $3M | 9.96% | +0.2% |
| BlackRock, Inc. | 1.7M | $1M | 4.37% | −1.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $773,563 | 2.96% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 858,799 | $580,274 | 2.22% | +16.5% |
| Jefferies Financial Group Inc. | 704,275 | $475,808 | 1.82% | +0.0% |
| Clearstead Advisors, LLC | 425,600 | $287,536 | 1.10% | −0.0% |
| STATE STREET CORP | 383,191 | $258,884 | 0.99% | −4.2% |
| Nuveen, LLC | 370,325 | $250,191 | 0.96% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.07 | — | $10.1M | +2.9% |
| 2025-12-31 | 2026-03-09 | — | — | $11.4M | −5.9% |
| 2025-09-30 | 2025-11-10 | −$0.09 | — | $10.1M | +9.6% |
| 2025-06-30 | 2025-08-11 | −$0.11 | — | $9.7M | +28.3% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
